The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Phosphates
potassium phosphates · MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL; DIBASIC POTASSIUM PHOSPHATE 236 mg/mL · Injection, Solution, Concentrate · Intravenous · Hospira, Inc.
NDC 00409-0032-01 · 25 VIAL, SINGLE-DOSE in 1 TRAY / 15 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$1,198.50
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2026 YTD · Q1)ⓘ
$82,978
23 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Hospira, Inc.United Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- ANDA217459
- TE code
- AP
- Approval date
- Sep 11, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of potassium phosphates (Injection, Solution, Concentrate)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hospira, Inc. | MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL; DIBASIC POTASSIUM PHOSPHATE 236 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Caplin Steriles Limited | POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL | Aug 26, 2026 | Aug 31, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL; DIBASIC POTASSIUM PHOSPHATE 236 mg/mL | Aug 26, 2026 | Aug 31, 2026 |
| Caplin Steriles Limited | POTASSIUM PHOSPHATE, MONOBASIC 236 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 224 mg/mL | Jul 22, 2026 | Aug 22, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | MONOBASIC POTASSIUM PHOSPHATE 236 mg/mL; DIBASIC POTASSIUM PHOSPHATE 224 mg/mL | Jul 22, 2026 | Aug 22, 2026 |
| Hospira, Inc. | MONOBASIC POTASSIUM PHOSPHATE 236 mg/mL; DIBASIC POTASSIUM PHOSPHATE 224 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Caplin Steriles Limited | POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL; POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL | Jul 15, 2026 | Jul 19, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | DIBASIC POTASSIUM PHOSPHATE 236 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL | Jul 15, 2026 | Jul 18, 2026 |
| Hospira, Inc. | DIBASIC POTASSIUM PHOSPHATE 236 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Phosphates — NDC 00409-0032-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00409003201.
Free to cite with attribution — see how the data is put together.